Central Nervous System Diseases: Clinical Trials

41585 trials for Central Nervous System Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21174 completed, 6671 unknown, 5718 recruiting, 2574 terminated. 17280 Not applicable, 5739 Phase 2, 3598 Phase 1, 3384 Phase 3, 1800 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable17280Completed 8478, Unknown 2977, Recruiting 2684, Not yet recruiting 1072, Terminated 788, Active not recruiting 564, Withdrawn 424, Enrolling by invitation 226, Suspended 67
Phase 25739Completed 3074, Unknown 652, Terminated 651, Recruiting 587, Active not recruiting 251, Withdrawn 241, Not yet recruiting 215, Enrolling by invitation 36, Suspended 32
Phase 13598Completed 2111, Recruiting 350, Terminated 324, Unknown 319, Active not recruiting 164, Withdrawn 149, Not yet recruiting 138, Suspended 24, Enrolling by invitation 19
Phase 33384Completed 1998, Terminated 395, Unknown 316, Recruiting 315, Not yet recruiting 131, Active not recruiting 121, Withdrawn 90, Enrolling by invitation 10, Suspended 8
Phase 41800Completed 1013, Unknown 313, Recruiting 150, Terminated 141, Not yet recruiting 81, Withdrawn 53, Active not recruiting 36, Enrolling by invitation 11, Suspended 2
Early Phase 1468Completed 195, Recruiting 82, Unknown 59, Terminated 41, Not yet recruiting 39, Withdrawn 25, Active not recruiting 21, Enrolling by invitation 5, Suspended 1

Follow this condition Literature Review of Central Nervous System Diseases trials Research Report on Central Nervous System Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury
Rehabilitation - Spinal Cord Injuries
Not applicableSuspendedIstituto Nazionale Assicurazione contro gli Infortuni sul Lavoro182030-01-012026-03-27
Observational Study to Assess Migraine Prediction Tool
Daily questionnaire - Migraine
SuspendedTheranica2002030-01-012024-11-22
Tau Pathology in the Brain After Hip or Knee Replacement Surgery
Hip or Knee Arthroplasty Under Spinal Anesthesia - Postoperative Cognitive Dysfunction, Alzheimer Disease
RecruitingUppsala University Hospital302029-04-012026-10-15
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN
Tetramethylpyrazine nitrone (TBN) tablet / Placebo - Healthy
Phase 1Not yet recruitingGuangzhou Magpie Pharmaceuticals Co., Ltd.162028-09-012026-09-11
A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas
RNS System Implantation - Glioma, Glioma Intracranial
Not applicableNot yet recruitingMedical College of Wisconsin32028-08-012026-10-13
The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
Vectris trial leads and stimulation, Sham - Vasospasm, Cerebral, Aneurysmal Subarachnoid Hemorrhage
Not applicableSuspendedUniversity of Alabama at Birmingham252028-07-312026-09-24
Terazosin And Metabolic Energetics in Parkinson's Disease
Terazosin 5 MG, Placebo - Parkinson's Disease (PD)
Phase 2SuspendedErgun Y. Uc1202028-07-012026-10-09
Device for Bladder Control for Men With SCI
Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder
Phase 1 / Phase 2Not yet recruitingVA Office of Research and Development122028-06-012026-06-25
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety
Phase 2Not yet recruitingXellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.602028-05-252025-11-25
Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma
JBI-778 - Brain Metastases From Solid Tumors, Leptomeningeal Disease
Phase 1 / Phase 2Not yet recruitingJubilant Therapeutics Inc.1132028-04-012026-08-07
Smartphone App for Adolescents With Idiopathic Scoliosis
DinSkoliose smartphone application - Adolescence Idiopathic Scoliosis, AIS
Not applicableNot yet recruitingOslo Metropolitan University302028-04-012026-07-07
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization
TEMMA Endovascular Treatment - Migraine Disorders, Refractory Migraine
Not applicableNot yet recruitingCortex Neurovascular252028-03-012026-10-20
Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy
Arm- and hand-use focused power mobility training - Cerebral Palsy, Hemiplegia, Infantile
Not applicableNot yet recruitingGrand Valley State University102028-01-192026-09-11
Sodium Lactate in Severe TBI
Sodium Lactate, placebo - Traumatic Brain Injury
Phase 2Not yet recruitingUniversity of California, Los Angeles2642028-01-102026-01-16
Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury
MUSE Stem Cell Therapy - Traumatic Brain Injury, Traumatic Brain Injury (TBI) Patients
Not yet recruitingHealing Hope International102028-01-012026-03-10
Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease
active subthalamic nucleus deep brain stimulation plus optimal drug therapy, inactive subthalamic nucleus deep brain stimulation plus optimal drug therapy - Parkinson Disease
Not applicableNot yet recruitingMallory Hacker402028-01-012026-02-20
To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria
GS1168 injection - Phenylketonuria (PKU)
Early Phase 1Not yet recruitingGritgen Therapeutics Co., Ltd.92027-12-312026-09-10
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
Acute stroke care Intervention arm - Acute Stroke
Not applicableNot yet recruitingThe George Institute3002027-12-302026-06-11
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Gemfibrozil, Placebo - Parkinson Disease
Phase 2WithdrawnForest Hills Lab2027-11-012026-08-19
Transcranial Magnetic Stimulation for Alzheimer's Disease Treatment
Active Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation - Alzheimer Disease
Not applicableNot yet recruitingUniversitat Oberta de Catalunya452027-11-012026-07-21

Showing 20 of 41585. Sign in to see all of them.

Narrower conditions

Stroke (7794)  ·  Parkinson Disease (4473)  ·  Alzheimer Disease (3874)  ·  Ischemic Stroke (2540)  ·  Brain Neoplasms (2363)  ·  Dementia (2249)  ·  Spinal Cord Injuries (1930)  ·  Cerebral Palsy (1829)  ·  Epilepsy (1806)  ·  Brain Injuries, Traumatic (1677)  ·  Cognitive Dysfunction (1576)  ·  Migraine Disorders (1484)  ·  Amyotrophic Lateral Sclerosis (972)  ·  Brain Injuries (918)  ·  Motor Activity (739)

Broader conditions

Nervous System Diseases (41157)  ·  Brain Diseases (36754)  ·  Vascular Diseases (13057)  ·  Cardiovascular Diseases (12970)  ·  Cerebrovascular Disorders (12365)  ·  Pathological Conditions, Signs and Symptoms (10924)  ·  Neurodegenerative Diseases (10569)  ·  Mental Disorders (7674)  ·  Signs and Symptoms (6934)  ·  Neurocognitive Disorders (6352)  ·  Neurologic Manifestations (6144)  ·  Movement Disorders (5680)  ·  Basal Ganglia Diseases (5448)  ·  Wounds and Injuries (5055)

Interventions

Transcranial Direct Current Stimulation (460)  ·  Exercise (358)  ·  Transcranial Magnetic Stimulation (281)  ·  Blood Specimen Collection (245)  ·  Sodium Chloride (243)  ·  Standard of Care (213)  ·  Aspirin (203)  ·  Magnetic Resonance Spectroscopy (203)  ·  Saline Solution (202)  ·  Temozolomide (198)  ·  Control Groups (189)  ·  Physical Therapy Modalities (177)  ·  Surveys and Questionnaires (175)  ·  Donepezil (172)  ·  Botulinum Toxins, Type A (160)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (374)  ·  Riphah International University (362)  ·  VA Office of Research and Development (336)  ·  Assistance Publique - Hôpitaux de Paris (330)  ·  Beijing Tiantan Hospital (242)  ·  Pfizer (237)  ·  National Taiwan University Hospital (230)  ·  Mayo Clinic (224)  ·  GlaxoSmithKline (216)  ·  Duke University (193)  ·  Chang Gung Memorial Hospital (191)  ·  Johns Hopkins University (191)  ·  Hospices Civils de Lyon (186)  ·  Xuanwu Hospital, Beijing (184)  ·  Cairo University (183)

Countries

United States (15152)  ·  France (3507)  ·  China (3395)  ·  Canada (2608)  ·  United Kingdom (2221)  ·  Italy (2159)  ·  Germany (2150)  ·  Spain (1904)  ·  Turkey (Türkiye) (1568)  ·  Belgium (1084)  ·  Taiwan (1077)  ·  Netherlands (1047)  ·  South Korea (1025)  ·  Australia (985)  ·  Denmark (936)

Results publications

PMID 36602886, PMID 38588457, PMID 33175411, PMID 34813082, PMID 37870112, PMID 31867054, PMID 39498781, PMID 33189083, PMID 34184251, PMID 34196963, PMID 40603145, PMID 12807523, PMID 35857365, PMID 36700520, PMID 18190818, PMID 37467180, PMID 11914403, PMID 20451898, PMID 34022170, PMID 34487721, PMID 40680102, PMID 16731270, PMID 21899409, PMID 34081125, PMID 34515113, PMID 36398903, PMID 39800465, PMID 15817019, PMID 22108357, PMID 2375765, PMID 25671797, PMID 26898852, PMID 26899665, PMID 31356217, PMID 31420846, PMID 32905623, PMID 33825230, PMID 34695300, PMID 35305920, PMID 37565307, PMID 40049590, PMID 8984084, PMID 24144944, PMID 24524452, PMID 27657681, PMID 31662037, PMID 32640944, PMID 33417236, PMID 33461041, PMID 34218211

NIH funding

2023 (144), 2018 (118), 2019 (112), 2014 (111), 2017 (103), 2025 (99), 2016 (92), 2015 (89), 2009 (68), 2008 (53), 2004 (27), 2005 (27), U10EY011751 (23), U54AG063546 (22), U01CA081457 (14)